Hutchmed Partners with GSK to Develop First-in-Class Cancer Drug in Licensing Deal Worth Up to $1.295 Billion — BigGo Finance
Hutchmed (00013.HK; HCM.US) announced on September 3 that its subsidiary, Hutchison Whampoa Pharmaceutical (Shanghai), has entered into an…